Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAurobindopharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy HDFC, ONGC; sell Tata Motors DVR, Aurobindo Pharma: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying HDFC and ONGC and advises selling Tata Motors DVR and Aurobindo Pharma.

    • Short Aurobindo Pharma, buy Tata Chemical: Kunal Bothra

      Kunal Bothra of LKP Securities is of the view that one may sell Aurobindo Pharma.

    • Buy Aurobindo Pharma, Dabur, M&M: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com suggests buying Aurobindo Pharma, Dabur India and Mahindra and Mahindra.

    • Buy Maruti Suzuki on all declines: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Maruti Suzuki on all declines.

    • Prefer Srikalahasthi Pipes: Prakash Diwan

      Prakash Diwan of prakashdiwan.in is of the view that one may prefer Srikalahasthi Pipes.

    • Buy Reliance Capital, SRF, Aurobindo Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Reliance Capital, SRF and Aurobindo Pharma.

    • Positive on NIIT Tech; ACC, JK Lakshmi top picks: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher has a positive view on NIIT Tech and Maruti Suzuki and has ACC and JK Lakshmi Cement as the top picks from the cement space.

    • Buy Karnataka Bank, GAIL, L&T Fin, Aurobindo Pharma: Rajat Bose

      Rajat Bose of rajatkbose.com recommends buying Karnataka Bank, GAIL India, L&T Finance Holdings and Aurobindo Pharma.

    • Buy Auro Pharma on every dip, HDFC may hit Rs 1127: Rajat Bose

      Rajat Bose of rajatkbose.com recommends buying Aurobindo Pharma on every dip and feels that HDFC may slip to Rs 1127.

    • Sell Bharat Forge, BEML; buy Auro Pharma, Petronet: Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling Bharat Forge, United Breweries and BEML and advises buying Aurobindo Pharma and Petronet LNG.

    • Bull's Eye: Buy Bata, HDFC, Havells; sell Dish TV, Hind Zinc

      Vishal Malkan of malkansview.com advises buying Bata India with a target of Rs 590.

    • Buy Federal Bank, Britannia; short Divis Lab: Rahul Shah

      Rahul Shah of Motilal Oswal Securities recommends buying Federal Bank and Britannia Industries and advises shorting Divis Lab.

    • Buy Infosys; sell Tata Motors, Union Bank: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Infosys and advises selling Tata Motors and Union Bank.

    • Sell Tech Mahindra; buy Aurobindo Pharma: Sandeep Wagle

      Sandeep Wagle of powermywealth.com is of the view that one can sell Tech Mahindra and buy Aurobindo Pharma.

    • Super 6 stocks that can give handsome returns today

      Kunal Saraogi of Equityrush recommends buying Aurobindo Pharma with a target of Rs 820 and advises selling ICICI Bank with a target of Rs 215.

    • Sell Coal India, YES Bank; buy Aurobindo Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling Coal India and YES Bank and advises buying Aurobindo Pharma.

    • Buy L&T, Strides Shasun, Future Retail: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Larsen and Toubro, Strides Shasun and Future Retail and feels that Aurobindo Pharma may test Rs 900.

    • Buy Aurobindo Pharma, Rolta India, Bharti Airtel: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Aurobindo Pharma, Rolta India and Bharti Airtel.

    • Like Dabur, L&T Fin may hit Rs 84, Century Ply Rs 200: Gaba

      Prakash Gaba of prakashgaba.com likes Dabur India and feels that L&T Finance Holdings may test Rs 84 while Century Plyboards may hit Rs 200.

    • Go long in JSPL, Maruti Suzuki looks good: Rajat Bose

      Rajat Bose of rajatkbose.com recommends going long in JSPL and feels that Maruti Suzuki looks good for a target of Rs 3930.

    • Sell Bharat Forge, IRB Infra; buy Jet Air, Tata Chem: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Jet Airways, Tata Chemicals and Glenmark Pharma and advises selling Bharat Forge and IRB Infra.

    • Buy SBI, Aurobindo Pharma; sell Jubilant Foodworks: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying State Bank of India, aurobindo Pharma and Jubilant Foodworks.

    • Buy Apollo Hospitals, TV18 Broadcast; sell Auro Pharma: Wagle

      Sandeep Wagle of powermywealth.com recommends buying Apollo Hospitals, TV18 Broadcast and Vadilal Industries and adviseds selling Aurobindo Pharma.

    • Buy Aurobindo Pharma, says CA Rudramurthy BV

      CA Rudramurthy BV of Vachana Investments advises buying Aurobindo Pharma.

    • Buy M&M Fin, Rallis, Rel Cap, L&T; sell Britannia: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Mahindra & Mahindra Financials Services, Rallis India, Reliance Capital, Larsen & Toubro and Aurobindo Pharma and advises selling Britannia Industries.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347